
The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …

Amgen and its development partner UCB have announced that the FDA has issued a complete response letter for the biologics …

The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …

The UK government has revealed that it will apportion £86 million to help the assessment of new technologies and increase …

Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …

Over a year ago, the Obama administration asked the National Academies of Sciences, Engineering, and Medicine to advise them on …

As the week comes to a close, we bring you the stories that were most read by our readers – …

The FDA has handed out another approval, as the agency now easily surpasses last year’s figure of 22 already, this …

Scientists from the University of Oxford have developed a heart scan that can identify inflammation around arteries that can suggest …

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

The government has announced its response to Dame Fiona Caldicott’s 2016 data security review and in the wake of the …

In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …

It is no secret that Teva has been on the lookout for a new CEO and they had already been …

Ocular Therapeutix received a second CRL for its drug, Dextenza, despite submitting a last-minute application for an extension to its …